Markus Pfirrmann

Markus Pfirrmann serves as Professor at the Institute of Medical Informatics, Biometry and Epidemiology (IBE) of Ludwig Maximilian University since 2024. He leads the "Registry Studies and Clinical Trials II" working group, focusing on advanced statistical methodology in clinical research. With a Master's in Applied Stochastic Systems from University College London and habilitation at LMU Munich (2016), his work bridges clinical questions and biostatistical innovation.

• Research Pillars
  • Prognostic score development for leukemia
  • Survival analysis with time-dependent covariates
  • Competing risk modeling in clinical trials
  • Therapy-free remission prediction
  • Pharmacogenomic biomarker discovery

His 30+ years of clinical trial leadership includes major studies like the CML V TIGER and EURO-SKI trials. Notable achievements include co-developing the EUTOS long-term survival score and receiving the Paul Martini Prize. Current methodological work emphasizes minimal residual disease monitoring and treatment de-escalation strategies.

• Scientific Awards
  • Paul Martini Prize (2000) for medical informatics contributions

As educator, he organizes the annual "Understanding Modern Statistics in Leukemia Trials" workshop at European LeukemiaNet symposiums and teaches clinical research methodology at Johannes Kepler University Linz. His 70+ peer-reviewed publications across Blood, Leukemia, and Lancet Oncology establish him as a key biostatistical authority in myeloid malignancies.